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A B S T R A C T
The European Forensic Genetics Network of Excellence (EUROFORGEN-NoE) undertook a collaborative
project on mRNA-based body ﬂuid/skin typing and the interpretation of the resulting RNA and DNA data.
Although both body ﬂuids and skin are composed of a variety of cell types with different functions and
gene expression proﬁles, we refer to the procedure as ‘cell type inference’. Nine laboratories participated
in the project and used a 20-marker multiplex to analyse samples that were centrally prepared and
thoroughly tested prior to shipment. Specimens of increasing complexity were assessed that ranged
from reference PCR products, cDNAs of indicated or unnamed cell type source(s), to challenging mock
casework stains. From this specimen set, information on the overall sensitivity and speciﬁcity of the
various markers was obtained. In addition, the reliability of a scoring system for inference of cell types
was assessed. This scoring system builds on replicate RNA analyses and the ratio observed/possible
peaks for each cell type [1]. The results of the exercise support the usefulness of this scoring system.
When interpreting the data obtained from the analysis of the mock casework stains, the participating
laboratories were asked to integrate the DNA and RNA results and associate donor and cell type where
possible. A large variation for the integrated interpretations of the DNA and RNA data was obtained
including correct interpretations. We infer that with expertise in analysing RNA proﬁles, clear guidelines
for data interpretation and awareness regarding potential pitfalls in associating donors and cell types,
mRNA-based cell type inference can be implemented for forensic casework.
 2014 Elsevier Ireland Ltd. All rights reserved.
Contents lists available at ScienceDirect
Forensic Science International: Genetics
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / fs ig1. Introduction
The potential of mRNA proﬁling to infer which body ﬂuid or
tissue resides in an evidentiary sample has been well demonstrat-
ed in the past decade. The identiﬁcation of speciﬁc, sensitive and* Corresponding author at: Department of Human Biological Traces, Netherlands
Forensic Institute, Laan van Ypenburg 6, The Hague 2497GB, The Netherlands.
Tel.: +31 70 8886666; fax: +31 70 8886555.
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http://dx.doi.org/10.1016/j.fsigen.2014.01.006robust markers, poses a continuous search that is undertaken for a
growing number of body ﬂuids and organs [2–23]. Evaluation of
the performance of these markers is well assisted by large
collaborative exercises that have been performed for several body
ﬂuids [24–27]. Suitable markers have been combined in end-point
reverse transcription PCR (RT-PCR) systems that assess the
presence of multiple cell types simultaneously [28–31]. Most of
these assays carry multiple markers per cell type, as expression of
individual mRNAs varies with biological function and for
individuals or physiological condition. As a result, RNA proﬁles
appear much less balanced than DNA proﬁles and sometimes
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presence of non-speciﬁc transcripts in a cell due to back ground
level gene expression or as a result of spurious transcription that
occurs whenever RNA polymerase binds to DNA. Variation in RNA
proﬁling data may be further stimulated by the use of a rather high
number of ampliﬁcation cycles (33 in [30], 35 in [24–27], 30 in
[29], 30 or 35 depending on the body ﬂuid in [31]), and stochastic
ampliﬁcation effects [33] are seen when replicate RNA analyses are
performed [32]. These issues have triggered the development of
interpretation strategies for RNA proﬁles that allow for some
marker absence and spurious signals [1,31]. The scoring method-
ologies have limitations with body ﬂuids that express markers of
other body ﬂuids as well and cannot discriminate co-expressed cell
types (e.g. blood co-expressed in menstrual secretion) from a
mixture of the two cell types (e.g. peripheral blood and menstrual
secretion). Mixed stains are challenging to interpret anyhow as one
donor may give multiple cell types or multiple donors the same cell
type. Combined interpretation of RNA and DNA proﬁling results
may be only possible when gender-speciﬁc body ﬂuids and donors
of different genders are involved, as peak height-based association
of donor and cell type was found to be risky even in straightfor-
ward two donor–two cell type mixtures [32].
A collaborative exercise was organised among the partners of
the European Forensic Genetics Network of Excellence (EURO-
FORGEN-NoE) in order to assess the value of mRNA analysis in a
forensic context. An RNA analysis system was taken that is
routinely used for casework at the Netherlands Forensic Institute
(NFI), and each participant was provided with the same set of
specimens that had increasing complexity. The most complex
samples were mock casework stains for which laboratories not
only scored the RNA results but also provided a forensic
interpretation, building on the estimated number and genders
of contributors, the cell types regarded present and, if possible,
association of donor and cell types. As these stains were designed
to be challenging and complex, potential pitfalls for integrated
DNA and RNA data interpretation become apparent.
2. Materials and methods
2.1. Samples and materials provided
The mRNA proﬁling exercise was divided into two parts: part
1 included puriﬁed PCR products and cDNA specimens and partTable 1
Overview of the samples and objectives assessed during the mRNA proﬁling exercise.
Part Samples 
1 Puriﬁeda PCR products, cell type indicated
7 samples: each cell typeb and blank
Single source cDNAs, cell type indicated
24 samples: 3 inputsc and minus RT for each cell type
cDNAs with unspeciﬁed cell type
10 samples: communicated as single source, but including one
mixture and one water sample
Mixed cDNAs, unspeciﬁed cell types
4 samples: mixtures of two or three body ﬂuids
2A Complex stains, unspeciﬁed cell types
4 samples: on a variety of substrates
2B NFI dataset for the four complex stains
1 DNA proﬁle and 4 replicate RNA proﬁles
a Puriﬁcation by MinElute columns using a low salt strength buffer to elute products. P
in this buffer, which is not the case if puriﬁed into water.
b Six cell types are included: blood, saliva, semen, vaginal mucosa, menstrual secret
c cDNAs were derived from three amounts of RNA.2 comprised mock casework stains. Details are provided in Table 1.
Specimens were prepared at the organising laboratory (NFI) with
informed consent of the voluntary donors whose cell material was
used. Saliva and semen were collected in tube, blood through a
ﬁnger prick (Accu-chek, Softclix Pro, Roche Diagnostics GmbH,
Germany), vaginal mucosa on cotton swab, menstrual secretion on
Viba brushes (Rovers, Oss, the Netherlands) and skin by rubbing
textiles over the face. Textiles used as substrates for stains were
freed from contaminating DNA by irradiating each side with
254 nm UV light in a CL-1000 UV CrossLinker (UVP, Upland, USA) at
900 mJ/cm2 for 30 min. For stain 1, equal amounts of saliva of two
donors were mixed and 40 mL were added to cotton swabs. For
stain 2, two Viba brushes with menstrual secretion (day
2 menstrual cycle) were gently shaken in 500 mL PBS (phosphate
buffered saline) for 0.5 h after which 200 mL whole blood were
added and 5 mL of the mixture were transferred to pieces of ﬂeece.
Since the menstrual secretion signals were surpassing those of
blood, 50 mL neat blood were added on top of the stain. For stain 3,
skin donor 1 rubbed one side and skin donor 2 the other side of a
patch of linen over the face. Then, spots of 1 mL 100-fold diluted
blood of one of these donors were placed on the linen and small
areas of cloth around these blood spots were excised. For stain 4,
nail clippings of relatively short nails having contact with skin
were collected and a fresh vaginal mucosa swab was rubbed over
the nail clippings to transfer cell material. After drying, 1 mL
seminal ﬂuid of an azoospermic male was added. All specimens
and reagents sent to participating laboratories were thoroughly
tested prior to shipment. When shipping part 1 reagents, an
amount of multiplex primer mix sufﬁcient for both exercise parts
was included so that all results were obtained using a single batch
of primer mix. Part 1 reagents and specimens were sent on dry ice
taking 1–7 days, when in part 2 only dried stains were sent normal
mail was used. When additional reagents such as extraction
chemistry were requested dry ice was used. These shipments took
between 3 and 9 days.
2.2. DNA/RNA extraction, DNA quantiﬁcation, reverse transcription
At the organising laboratory, samples were subjected to DNA/
RNA co-extraction, quantiﬁcation of DNA extracts, DNase treat-
ment of RNA extracts and reverse transcription (both plus RT
reaction and minus RT control) of 10 mL RNA aliquots as described
in [30]. In each extraction, a negative and positive control (water orTasks and objectives
Adjust provided bin sets
CE sensitivity differences for laboratories
One PCR per sample with 1 mL cDNA input
Overall marker sensitivity and frequency of marker drop-in
Two PCRs per sample: 0.5 mL and 2.0 mL input
Familiarisation serial cDNA input approach
Overall performance: marker drop-ins and marker dropouts
Determine optimal cDNA input from 0.5 mL and 2.0 mL tests
Generate four informative replicates for scoring RNA results
Overall usefulness of scoring system
Extraction, DNA/RNA proﬁling and questionnaire
DNA: estimated minimum number of contributors and genders
RNA: scoring peaks and cell types
Interpretation: cell types present and association donor/cell type
Compare interpretations for same dataset
rior to shipment it was tested that the ﬂuorescently labelled PCR products are stable
ion and skin.
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show signals, positive controls showed correct peaks (housekeep-
ing and blood markers only). For preparation of cDNA specimens,
an appropriate number of cDNA batches (20 mL each) were pooled
and redistributed into aliquots of 5–20 mL. All protocols were
provided as example protocols, but participants could use
chemistries and instrumentations of choice. An overview of the
methodologies used during stain analysis is presented in
Supplementary Table 1. Participating laboratories were asked to
use the entire stain to prevent differences from using less material.
For low level samples (indicated by a DNA yield below 2 ng), it was
advised to concentrate the RNA extract down to 12 mL by applying
an ethanol precipitation as described in [30] and use 10 mL in a
single plus RT cDNA reaction and 2 mL in a minus RT cDNA control.
2.3. Endpoint PCR
The 19-plex described in [30] was supplemented with vaginal
mucosa marker CYP2B7P1 [19] (amplicons size 146 bp; forward
primer 50-VIC-AGTCTACCAGGGATATGGCATG; reverse primer
50-CTATCAGACACTGAGCCTCGTCC; ﬁnal primer concentration
1.6 mM), menstrual secretion marker MMP10 [5,27] (amplicons
size 107 bp; forward primer 50-VIC-GCATCTTGCATTCCTTGTG-
CTGTTG; reverse primer 50-GGTATTGCTGGGCAAGATCCTTGTT;
ﬁnal primer concentration 1.6 mM) and skin marker LCE1C
[16,18] (amplicons size 99 bp; forward primer 50-NED-TGTGACCC-
CGCTCCTGAATCCG; reverse primer 50-CTTGGGAGGGCACTTGG-
GGGTG; ﬁnal primer concentration 0.02 mM). To create the
space in the multiplex to add these three markers, the general
mucosa markers KRT13 and SPRR2A were removed. In this way, a
20-plex was created. A large batch of 5 primer stock for this
multiplex was prepared and aliquoted to provide all laboratories
with the exact same primer mixture in all RT-PCRs.
The suggested cDNA inputs in the RT-PCR analyses were 1 mL
for cDNA specimens with indicated cell type, 0.5 and 2 mL for cDNA
samples with unspeciﬁed cell type(s), 0.1, 0.5, 1 and 4 mL for stain
cDNAs and 3.5 mL for minus RT, negative and positive controls.
2.4. Capillary electrophoresis and analysis of DNA and RNA proﬁles
Ampliﬁed fragments were separated and detected on various
types of standard genetic analysers using different separation
matrices as indicated in Supplementary Table 1. As RT-PCR
products are generated using a homemade multiplex, removal
of dye-blobs prior to analysis is essential, and the various
approaches used are indicated in Supplementary Table 1. For
the analysis of RNA proﬁles, a 150 rfu detection threshold was
suggested by the organising laboratory [30]. However, some labs
used a lower threshold of 50 or 100 rfu as indicated in
Supplementary Table 1. No intervention occurred because peaks
were just below or above threshold. For the analysis of DNA
proﬁles, participating laboratories used their own protocols.
2.5. Scoring of RNA data
Following the procedure described in [1], four replicate RNA
proﬁles were generated using an informative cDNA input, and
the RNA data were evaluated by applying an ‘x = n/2’ scoring
system per cell type [1]. Here, ‘x’ reﬂects the number of observed
and ‘n’ the number of theoretically possible peaks in all
replicates. A cell type is scored as ‘observed’ if x  n/2, ‘not
observed’ if x = 0 and ‘sporadically observed’ if 0 < x < n/2. For
co-expressed cell types, ‘and ﬁts’ is added when (sporadically)
observed. Cell types scored as ‘sporadically observed’ are
generally regarded as ‘not reliably observed’ and tissues scored
as ‘and ﬁts’ as ‘not present as such’ [1].3. Results
3.1. Analysis of cDNAs
Nine laboratories including the organising laboratory partici-
pated in the exercise. All laboratories had experience with RNA
analyses; eight had participated (one as organiser) in EDNAP RNA
exercises [24–27]. The exercise started with the analysis of
reference RT-PCR, which enabled adjustment of the provided
marker bin settings in the analysis software if necessary. Some
differences in peak heights occurred; one participant had on
average 2.5 times higher peaks than the organising laboratory
while another had approximately 0.5 times lower peaks, which
seems due to the use of lower injection settings (Supplementary
Table 1).
The next set consisted of 24 cDNA specimens derived from
three RNA inputs and a minus RT control for each of the six cell
types. The results are presented in Table 2 and differences in
marker sensitivity are evident. Although this ﬁnding may have
been affected by the use of a single donation for each cell type, the
trends beﬁt observations in the organising laboratory. The
difference is most extreme for the vaginal mucosa markers: whilst
CYP2B7P1 responds almost fully for the three RNA inputs, no peaks
are obtained for HBD1 and only some for MUC4. For HBD1 this
probably derives from suboptimal performance in multiplex
analysis [30]. For the housekeeping markers, GAPDH appears to
be the least and 18S-rRNA the most robust marker. Non-speciﬁc
signals are occasionally seen both in non-target cell types and in
minus RT samples by all laboratories. Three cases appear more
frequent: (1) blood and especially CD93 signals for vaginal mucosa,
which is unprecedented and may have been the result of a trace of
blood (or menstrual secretion for which CD93 appears the most
prominent blood marker) in this speciﬁc donation; (2) skin marker
signals (LOR and to lesser extent CDSN) for vaginal mucosa,
indicating that LCE1C is the more speciﬁc skin marker and (3)
MMP10 signals for various non-target cell types and minus RT
blanks, which may be related to the relatively high signals for true
MMP10 peaks, which are on average 5320 rfu, while for the other
markers the average height ranges from 495 rfu (MUC4) to
3190 rfu (HBB). A lower primer concentration for MMP10 may
be beneﬁcial.
The next task involved the analysis of ten numbered cDNA
specimens, indicated to be single source but purposefully
comprising eight single source cDNAs (blood, saliva, two times
skin, vaginal mucosa, menstrual secretion, semen fertile donor,
semen azoospermic male), one mixture (vaginal mucosa with
blood) and one water sample. To illustrate the effect of cDNA input
on RNA proﬁling results, participants were asked to generate two
RNA proﬁles with a four-fold difference in cDNA input (0.5 and
2.0 mL, respectively). In theory, the participants can detect a total
of 208 cell type-speciﬁc peaks for the ten cDNA specimens with
each cDNA input. Using the 0.5 mL input, 109 peaks were detected
and with the higher input (2 mL except for one laboratory that used
1 mL), 161 peaks were observed. Marker dropout was predomi-
nantly seen for vaginal mucosa marker HBD1 and blood marker
AMICA1, which are both among the less sensitive markers when
testing the RNA input series (Table 2). Peaks detected using both
the 0.5 mL and the 2 mL input (91 in total) are on average 3.9 times
higher for the 2 mL, which complies with the four-fold increased
input. With a higher amount of cDNA, more non-target peaks were
seen as well: 21 for the lower and 42 for the higher input, which is a
total of 63 marker drop-ins in 140 RNA proﬁles. Again, skin
markers LOR and CDSN gave false positive signals in vaginal
mucosa and menstrual secretion specimens (23 and 16 observa-
tions for LOR and CDSN respectively), and menstrual marker
MMP10 showed occasional drop-in signals (13 times) among all
Table 2
Percentages of detected markers when analysing cDNAs derived from three inputs of single source RNAs. For each cDNA specimen, one RNA proﬁle was produced by each
participant with an input of 1 mL cDNA (Table 1).
aResults are based on the data of eight laboratories as one laboratory used an unsuccessful method to purify PCR products.
bSix minus RT samples (one per cell type) were provided to each participant and percentages are based on 48 proﬁles.
cCorrect marker signals are shaded green, false positive signals are shaded red. Darker shades indicate that a higher percentage of laboratories observe the signal.
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marker calling for the mixture and the water sample was not
affected by labelling them as single source cDNAs.
The last set of cDNAs involved four mixtures having two or
three cell types in balanced (1:1, based on the corresponding DNA
proﬁles) or unbalanced (up to 1:10) ratios. Participants were asked
to determine optimal cDNA input from the proﬁling results for a
0.5 and 2 mL input and generate four replicate RNA proﬁles for
application of the ‘x = n/2’ scoring system. The results are
presented in Table 3. It becomes apparent that it is helpful to
use the category ‘sporadically observed’ (which we generally
regard as not observed) as this category was used 21 times for cell
types not present in the mixtures and nine times for cell types
present. In total, a cell type was missed eleven times, which in
seven events concerned skin being the lowest component in
mixture four (ratio 10:5:1) (Table 3). The other four missed
inferences relate to three different components in three mixtures
(Table 3). A false positive skin identiﬁcation was obtained by all
participants in the third mixture. This seems a consequence of the
unintended responses of LOR and lesser extent CDSN in vaginal
mucosa: in the 32 RNA proﬁles generated by the eight participants
for this mixture, 29 LOR, 18 CDSN and no LCE1C signals were seen.
It seems beneﬁcial to remove LOR from the multiplex or exclude
LOR results from interpretation by the scoring system.
3.2. Analysis of stains
Exercise part 1 on the cDNA sets familiarised participants
with RNA proﬁle analysis using the provided 20-plex and theapplication of the ‘x = n/2’ counting system. The results were
provided as feedback prior to the second exercise part that
involved DNA and RNA analysis of challenging mock casework
stains. The design of the four stains is given in Table 4. The
participants were asked to estimate the number and genders of
the donors, derive a result score for each cell type using to the
‘x = n/2’ counting system and determine which cell types are
present or not present (or ‘no statement’). Both LOR and HBD1
were excluded during scoring because of non-speciﬁc signals
with vaginal mucosa or insufﬁcient multiplex ampliﬁcation.
Participants used various methodologies to extract nucleic acids
and derive DNA and RNA proﬁles (Supplementary Table 1), and
yields and proﬁling outcomes showed considerable variation
(Table 5, Supplementary Figure 1).
For stain 1 (two females giving saliva), all participants scored
saliva, which is the only body ﬂuid present, as observed. Four times
a cell type not present in the stain was scored as observed: once
blood, once menstrual secretion and twice skin. Two of these false
positives (blood and once skin) relate to the use of a lower
detection threshold than that of 150 rfu advised by the organising
laboratory. The false menstrual secretion score relates to the
analysis of slightly overloaded RNA proﬁles in which trailing
signals occur about ten nucleotides before the parent peaks: the
trailing signal of saliva marker HTN3 ﬁts the bin of the MMP7
menstrual secretion marker (although 0.3 nt smaller than true
MMP7 peaks), and together with MMP10 background signals (also
seen in part 1, Table 2) menstrual secretion gets scored ‘observed’.
Actually all peaks including those for housekeeping markers show
these trailing signals and with more expertise in analysing RNA
Table 4
Design of the four stains that compose part 2 of the exercise.
Substrate Preparation Challenge
1: Cotton swab Saliva ,D1 & saliva ,D2: daughter & mother; unequal
DNA amounts
One body ﬂuid by two donors; Parent–child relation between donors
2: Coloured ﬂeece Skin ,D1 & menstrual secr. ,D1 & blood <D2 Presence blood masked by menstrual secretion; Skin and menstrual secretion given by
same donor
3: Green linen Skin ,D1 & diluted blood ,D1 & skin ,D2 Low amount: EtOH precipitation may be needed; Donor 1 gives two cell types, skin
given by two donors
4: Nail clipping Nail/skin <D1 & vaginal muc. ,D2 & semen
azoospermic male <D3
Only two of three donors will contribute DNA; Male DNA part represents skin and not
seminal ﬂuid
Table 3
Results of the analysis of four cDNA mixtures. Participants generated four informative RNA proﬁles and applied ‘x = n/2’ counting system that scores results into ﬁve different
categories [1].
aColour coding for cell types is: black cell = present; white cell = not present; grey cell = co-expressed.
bColour coding of table cells for the results is: green cell = correct i.e. not observed when not present or observed (& ﬁts) when present; light green cell = sporadically observed
(regarded not observed) when not present; red cell = incorrect i.e. observed but not present or not observed when present; light red cell = sporadically observed (regarded not
observed) but present; grey cell = aberrant result for co-expressed cell types.
Table 5
Summarised results of the DNA and RNA data for the four stains (Table 4) that compose part two of the exercise.
aData of eight laboratories are included; for one laboratory the replicates seem contaminated by multiple cell types.
bNo standard deviation is provided; results per participant are given in Supplementary Figure 1.
cFor donor 3 no speciﬁc alleles were observed.
dBoth the categories ‘observed’ and ‘observed & ﬁts’ or ‘sporadically observed’ and ‘sporadically observed & ﬁts’. For more details see Supplementary Table 1.
eColour coding of table cells for the results is: green cell = correct i.e. observed when present or not observed or sporadically observed when not present; red cell = incorrect i.e.
not observed or sporadically observed when present or observed but not present.
fOnly the added cell types, not co-expressed cell types are regarded (so skin, blood and menstrual but not vaginal).
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signals may have been recognised. The fourth false positive
observation (skin) seems to relate to the analysis of slightly over-
ampliﬁed proﬁles on a 3500 genetic analyser. The dynamic rfuTable 6




Total Male X Y Proﬁle
Stain 1: ,D1 child & ,D2 parent 1.02 0.0 1651 – 36 
Stain 2: ,D1 & <D2 1.23 0.12 1719 345 52 
Stain 3: ,D1 major & ,D2 minor 0.02 0.0 1348 – 35 
Stain 4: <D1 minor & ,D2 major & <D3 sterile 0.54 0.01 2391 – 30 
B Blood Saliva Semen 
Stain 1: – Saliva – 
Marker count 0/12 8/8 0/8 
Result scorec 7x not obs 7x obs 7x not obs 
Presence score 7x not present 7x present 7x not present 
Stain 2: Blood – – 
Marker count 8/12 0/8 0/8 
Result score 4x obs; 3x obs&ﬁts 7x not obs 7x not obs 
Presence score 4x present; 1x not
present; 2x no
statement
7x not present 7x not present 
Stain 3: Blood – – 
Marker count 11/12 0/8 0/8 
Result score 7x obs 7x not obs 7x not obs 
Presence score 7x present 7x not present 7x not present 
Stain 4: – – Semen (sterile) 
Marker count 2/12 0/8 4/8 
Result score 6x spor; 1x spor&ﬁtsf 7x not obs 5x obs; 1x sporg;
1x spor&ﬁtsh
Presence score 2x no statement;
5x not present
7x not present 6x present (3x steri
1x no statement
C Overall interpretation 
Stain 1: ,D1 child
saliva & ,D2 parent
saliva
1x ,major = saliva, ,minor = saliva 
3x ,major = saliva, ,minor = saliva or unknown cell type 
1x ,major = saliva, presence 2nd donor not conﬁrmed 
2x Two , donors and saliva, no association 
Stain 2: ,D1
skin & menstrual & <D2
blood
1x , = menstrual, < = skin 
2x , = menstrual, < = skin or blood; , = menstrual, < = probably skin 
2x , = menstrual, < = skin and/or blood; , = ms, < no assoc. 
1x , = menstrual, skin no statement, blood either , or < donor 
1x , & < DNA donor, menstrual & skin (blood co-expressed), no association 
Stain 3: ,D1 major
skin & diluted blood & ,D2 minor
skin
4x Two ,DNA donors, blood & skin, no association 
1x ,major = skin, ,minor = blood or ,D1 = skin + blood, ,D2 = unknown 
1x Conﬁdent on one , donor, blood & skin will be from her 
1x , donor and skin present, possibly 2nd , giving blood or sporadic
menstrual with blood co-expressed, no association
Stain 4: <D1 minor
skin (nail) & , D2 major
vaginal & <D3 azoospermic
semen
2x ,major = vaginal + (probably) skin, <minor = semen 
1x ,major = vaginal, <minor = semen, skin no statement 
2x One , donor = vaginal + skin, semen not reliable or only RNA 
1x , and unknown, skin & vaginal & seminal ﬂuid, no association 
1x No report: discrepancy observing semen while no < genotype 
a Sensitivity Alu-based DNA quantiﬁcation system is >0.0005 ng/mL for total and >0
b Allele counts on 15 STRs, amelogenin excluded. Donor-speciﬁc counts involve only
c Observed is abbreviated obs, sporadically observed as spor. Results of 7 participan
d Laboratory 4: skin signals may be a false positive response (3 CDSN and 1 LCE1C p
e Laboratory 1: scoring for menstrual and vaginal swapped?
f Laboratory 7: the 2 blood peaks are sporadic and may ﬁt vaginal.
g Laboratory 8: 4/8 semen peaks scored as ‘sporadically observed’, and interpreted a
h Laboratory 1: 4/8 semen peaks scored as ‘sporadically observed & ﬁts’, interpreted
i Laboratory 1: 8/8 skin peaks scored as ‘sporadically observed & ﬁts’, interpreted as
j Laboratory 1: 6/8 vaginal peaks scored as ‘not observed’, interpreted as ‘not presenrange of the 3500 platform is approximately four-fold higher than
that of the 3130XL platform that was used to generate the provided
analytical thresholds. Concomitantly, true signals had up to
34,000 rfu while the false skin signals were between 800 anding DNA (A), RNA (B) and combined results (C).
er allelesb Donor 1b Donor 2b Interpretation DNA results
 Locus Alleles Rfu Alleles Rfu
3 10/10 509 10/11 95 4x two ,; 2x , & unknown;
1x one ,
4 26/26 620 26/26 576 7x , & <
4 17/17 523 6/19 75 3x two ,; 2x , & unknown;
2x one ,





7x not obs 7x not obs 7x not obs
7x not present 7x not present 7x not present
Skin Menstrual –
4/8 12/12 0/8
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analytical thresholds need to be re-established.
For stains 2, 3 and 4, no false positive scorings occur (Table 5).
However, for these three stains not all cell types present were
scored as observed. For stain 2 (female giving menstrual secretion
and skin plus male giving blood), all participants observed
menstrual secretion, while blood was scored as observed by six
and skin by ﬁve of the eight laboratories. This is striking for blood
as the blood donor corresponds to almost half of the total rfu
weight in most of the DNA proﬁles. Apparently, blood gives
relatively low RNA signals compared to the DNA signals or
menstrual secretion gives relatively low DNA signals compared to
the RNA signals indicating, as already shown in [32], that it is not
appropriate to associate the strongest signals from RNA and DNA
typing of co-extracted samples with each other. Stain 3 (skin and
diluted blood from one female plus skin from another female) was
challenging due to the low amounts of cell material present, which
is reﬂected by a low number of observed scorings for present cell
types: blood is scored only once and skin ﬁve times as observed
(Table 5). Only two of the participants proceeded to ethanol
precipitation of the RNA prior to cDNA synthesis, and the one
positive scoring for blood was obtained by one of these
participants. For stain 4 (nail clipping from a male with vaginal
mucosa female and seminal ﬂuid azoospermic male), skin and
vaginal mucosa were scored as observed by six laboratories while
semen was reported as observed four times. Since the semen
contribution is of an azoospermic male, only the seminal ﬂuid
marker SEMG1 will respond. To have semen scored as ‘observed’,
SEMG1 needs to give a positive signal in all four replicates.
Actually, this was only the case for three of the four laboratories:
one participant had three (true) SEMG1 signals and one (false)
PRM1 peak that was a pull-up from the LOR signal, which could
have been recognised by peak shape and size as it was 0.9
nucleotide larger than a true PRM1 signal. When considering the
scorings of all stains together, 4% were false positives scores that
can be explained from suboptimal proﬁle analysis and 11% were
false negative scores (Table 5). The category ‘sporadically observed
(& ﬁts)’ was used for 13% of the scorings for cell types present and
for 21% of the scorings for cell types not present, suggesting that
this is a useful category as it seems to lower the number of false
positive results.
3.3. Combined interpretation of DNA and RNA data for the stains
Using the inferences on donor numbers, their genders and the cell
types observed, participants were requested to give a combined
interpretation of DNA and RNA data. However, the underlying
proﬁling data were so different that it was not constructive to
compare these interpretations, and the dataset of the organising
laboratory was sent out. This set consisted of the DNA quantiﬁcation
results (total and male-speciﬁc), one DNA proﬁle and four RNA
replicate proﬁles for each stain. Characteristics of this dataset are
summarised in Table 6. The participants estimated the number and
genders of the donors, derived a result score for each cell type and
determined which cell types are present or not present, or receive ‘no
statement’. With stains 1, 3 and 4 participants provided different
responses for the numbers and genders of donors (Table 6),
indicating that the exact same DNA data are evaluated differently.
The cell type scorings are mainly in accordance with the provided
guidelines (Table 6). In all cases when cell types were scored as not
observed, participants indicated these cell types as not present. Cell
types scored as observed were always regarded present. Blood in
stain 2 was classiﬁed four times as observed and three times as
observed and ﬁts because menstrual secretion signals were detected
as well. In all instances when ‘observed and ﬁts’ was chosen, ‘no
statement’ was selected for presence. The sporadic signals seen formenstrual secretion in stain 3 and blood in stain 4 received different
interpretations; six times the corresponding cell types were
regarded as not present and six times ‘no statement’ was made.
The interpretations for the DNA and RNA data were combined
into a verbal conclusion in which donors and cell types were
associated, if possible. For stains 1, 2 and 3 the majority of the
verbal conclusions are correct, have a correct interpretation among
the multiple options given in the statement, or leave room for the
correct alternative by using ‘probably’ (Table 6). For stain 2 twice
an incorrect interpretation was given that appears to derive from
not recognising that in case menstrual secretion is present blood
signals may also originate from a peripheral blood contribution.
For stain 4, which was clearly the most complex stain that was sent
out, no correct interpretation was provided. In this stain, the
presence of the second male donor giving seminal ﬂuid is fully
masked at the DNA level by the female giving vaginal mucosa and
the ﬁrst male providing the nail clipping. Sterile seminal ﬂuid does
not carry spermatozoa, but low amounts of epithelial cells may be
present and provide some DNA. Actually when a Y-STR proﬁle was
generated, all alleles of the nail donor and some low level signals
for the seminal ﬂuid donor were visible (results not shown).
Most of the incorrect interpretations associated the male DNA
component with the semen contribution without realising that
this male may have provided the skin residing on the nail clipping
and another male the seminal ﬂuid. Other participants under-
estimated the number of contributors and consequently linked
both vaginal mucosa and skin to the female donor, while she only
provided vaginal mucosa. One participant reported a discrepancy
for the lack of a male proﬁle while a positive result for semen was
obtained, which implies that the azoospermic status of the donor
was not recognised. It is also noticed that some participants were
very reluctant to make associations such as for stain 1 for which
one participant did not link the major DNA contributor to saliva
(Table 6). Interestingly, sometimes participants mentioned that
DNA signals may derive from unknown cell types or cell types
‘below detection’, while they had indicated that the not observed
cell types were all ‘not present’. Apparently, ‘not present’ is rather
used as ‘seemingly not present, but there may be signals below
detection’ and terms like ‘no indication for presence’ or ‘the
presence can not be excluded’ may be more appropriate.
4. Discussion and concluding remark
This collaborative EUROFORGEN-NoE exercise explored the
usefulness of forensic cell type inference by mRNA proﬁling. The
methodology would expedite from a good human RNA quantita-
tion system. The exercise used a 20-marker multiplex in which
most markers performed acceptably except skin marker LOR that
showed cross-reactivity with vaginal mucosa and vaginal mucosa
marker HBD1 that had low ampliﬁcation success. These markers
are best removed or replaced in an updated future multiplex. The
addition of a second seminal ﬂuid marker would increase the
detection chance of semen from azoospermic males since now, a
signal is needed in all four replicates to conﬁrm presence.
Furthermore, the primer concentrations for menstrual secretion
marker MMP10 can be lowered to prevent background signals and
over-ampliﬁcation. Redesign of the multiplex is challenging
because of multiplex spacing and marker balance. RNA amplicons
are preferably sized between 70 and 150 bp to allow analysis of
compromised samples. Consequently, limited space is available for
markers and recurrent bleed-through and artefact signals (split
peaks and trailing signals) that should not culminate in the bins of
other markers. Primer concentrations need to be such that both
good sensitivity and low noise levels are obtained. Furthermore,
the use of a relatively high detection threshold appears beneﬁcial
to prevent false positive marker callings. Experience with the
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recognised.
Even for an optimised multiplex, it may be inevitable that RNA
proﬁles have signal imbalances, marker dropout and marker
drop-in, as mRNA expression is inﬂuenced by various biological
factors. To assess the validity of cell type signals, interpretation
guidelines are applied. In this study, we used the ‘x = n/2’ scoring
system [1]. This system worked adequately as only few false
positive scores were obtained (Table 5), which were predomi-
nantly due to signal calls on artefact peaks. Employing these
guidelines may come at the cost of not inferring all cell types that
are present, which is important to keep in mind during case
interpretation. As an alternative approach, a numerical scoring
method is described [31] in which values are assigned to each of
the used mRNA markers (ﬁve per body ﬂuid) based on correct and
incorrect expression in samples of known origin. From these
numerical values a body ﬂuid score is calculated and positive
body ﬂuid identiﬁcation is given when the combined marker
value is higher than a pre-determined threshold value. This is
clearly different from the ‘x = n/2’ scoring system, in which all
markers have the same weight, implying that all markers are
evenly effective for cell type inference. This is not always the case
as for instance seminal ﬂuid and spermatozoa markers respond
different when analysing semen of an azoospermic male (which
could be compensated by adding a second seminal ﬂuid marker
or by scoring presence of seminal ﬂuid upon regarding SEMG1
results only). On the other hand, the ‘x = n/2’ method presents a
general approach applicable to different mRNA proﬁling assays
like cell and organ typing [21,30]. A comparative study including
compromised samples would be informative to assess both
interpretation strategies.
In a forensic case, DNA and RNA data need to be combined.
Distribution of a DNA/RNA dataset derived for four truly
challenging stains assessed this aspect. These stains covered the
most prominent complications in DNA/RNA proﬁling such as same
cell type given by multiple donors (stains 1 and 3), same donor
giving multiple cell types (stains 2 and 3), masking of a cell type
(blood, stain 2) by a co-expressing cell type (menstrual secretion),
low level analysis (stain 3) and a cell type giving RNA but no (or
hardly) DNA signals (seminal ﬂuid azoospermic male, stain 4). No
helpful context information such as ‘the nails were clipped from
person X’ or reference proﬁles were given. In addition, not all
participants were experienced with formulating forensic verbal
statements. While for stains 1, 2 and 3 many correct interpreta-
tions were given, none of the interpretations for stain 4 were
correct. This stain represents the forensic analysis of nail clippings
taken from an assailant of digital penetration of a victim who had
had previous intercourse with an azoospermic male. Although this
is an unusual scenario, it may happen and serves to illustrate that
awareness regarding such interpretation pitfalls is important
when proceeding to RNA analysis in forensic casework.
In conclusion, with expertise in analysing RNA proﬁles, clear
guidelines for data interpretation and awareness regarding
potential interpretation pitfalls mRNA-based cell type inference
may be ready for implementation in forensic casework.
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